Sernova Biotherapeutics Inc (FRA:PSH0)
0.0825
-0.0170 (-17.09%)
Last updated: Jun 23, 2025
Sernova Biotherapeutics Statistics
Total Valuation
FRA:PSH0 has a market cap or net worth of EUR 34.59 million. The enterprise value is 36.34 million.
Market Cap | 34.59M |
Enterprise Value | 36.34M |
Important Dates
The last earnings date was Wednesday, June 11, 2025.
Earnings Date | Jun 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 328.48M |
Shares Outstanding | n/a |
Shares Change (YoY) | +5.24% |
Shares Change (QoQ) | +0.31% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 315.06M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -2.62 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -2.59 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
Current Ratio | 0.12 |
Quick Ratio | 0.10 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -20.38 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -167.56% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 107.82% |
Revenue Per Employee | n/a |
Profits Per Employee | -876,174 |
Employee Count | 17 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, FRA:PSH0 has paid 32,070 in taxes.
Income Tax | 32,070 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -65.62% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -65.62% |
50-Day Moving Average | 0.12 |
200-Day Moving Average | 0.14 |
Relative Strength Index (RSI) | 42.51 |
Average Volume (20 Days) | 4,134 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -13.37M |
Pretax Income | -13.99M |
Net Income | -14.02M |
EBITDA | -13.18M |
EBIT | -13.37M |
Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 1.27 million in cash and 3.02 million in debt, giving a net cash position of -1.75 million.
Cash & Cash Equivalents | 1.27M |
Total Debt | 3.02M |
Net Cash | -1.75M |
Net Cash Per Share | n/a |
Equity (Book Value) | -13.18M |
Book Value Per Share | -0.04 |
Working Capital | -13.02M |
Cash Flow
Operating Cash Flow | -10.25M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
FRA:PSH0 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.24% |
Shareholder Yield | n/a |
Earnings Yield | -40.53% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |